Column Capital Advisors, LLC Pfizer Inc Transaction History

Column Capital Advisors, LLC

$1.92 Billion
Q3 2023

A detailed history of Column Capital Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Column Capital Advisors, LLC holds 18,641 shares of PFE stock, worth $489,139. This represents 0.03% of its overall portfolio holdings.

Number of Shares

18,641

Previous 18,625 0.09%

Holding current value

$489,139

Previous $683,000 9.52%

% of portfolio

0.03%

Previous 0.03%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 03, 2023	BUY	$32.09 - $37.51 $513 - $600	16 Added 0.09%	18,641 $618,000
Q2 2023 Aug 08, 2023	SELL	$36.12 - $41.79 $32,038 - $37,067	-887 Reduced 4.55%	18,625 $683,000
Q1 2023 May 09, 2023	BUY	$39.39 - $51.28 $34,702 - $45,177	881 Added 4.73%	19,512 $796,000
Q4 2022 Feb 06, 2023	BUY	$41.75 - $54.5 $533,064 - $695,856	12,768 Added 217.77%	18,631 $955,000
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $481 - $587	11 Added 0.19%	5,863 $257,000
Q2 2022 Aug 04, 2022	BUY	$46.53 - $55.17 $19,682 - $23,336	423 Added 7.79%	5,852 $307,000
Q1 2022 May 03, 2022	BUY	$45.75 - $56.69 $37,103 - $45,975	811 Added 17.56%	5,429 $281,000
Q4 2021 Feb 07, 2022	BUY	$41.32 - $61.25 $37,601 - $55,737	910 Added 24.54%	4,618 $273,000
Q3 2021 Nov 10, 2021	BUY	$39.25 - $50.42 $392 - $504	10 Added 0.27%	3,708 $160,000
Q2 2021 Aug 05, 2021	BUY	$35.91 - $40.68 $45,318 - $51,338	1,262 Added 51.81%	3,698 $145,000
Q2 2020 Aug 12, 2020	SELL	$30.12 - $36.54 $90,360 - $109,620	-3,000 Reduced 55.19%	2,436 $79,000
Q1 2020 May 11, 2020	SELL	$27.03 - $38.62 $20,218 - $28,887	-748 Reduced 12.1%	5,436 $177,000
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $203,577 - $231,034	6,184 New	6,184 $242,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.73B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $147B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Column Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Column Capital Advisors, LLC with notifications on news.

Account

Column Capital Advisors, LLC Pfizer Inc Transaction History